LRP8 and Alzheimer disease: To confirm the frequency of inclusion of APOER2 ex15 in the parietal cortex, which was previously demonstrated to have reduced inclusion in AD compared to controls (Fig 4A), we designed RT-PCR primers targeting APOER2 ex15 (Fig 4C).